Rathbones Group PLC Bristol Myers Squibb CO Transaction History
Rathbones Group PLC
- $17.8 Billion
- Q2 2024
A detailed history of Rathbones Group PLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Rathbones Group PLC holds 37,853 shares of BMY stock, worth $1.99 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
37,853
Previous 40,150
5.72%
Holding current value
$1.99 Million
Previous $2.18 Million
27.79%
% of portfolio
0.01%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding BMY
# of Institutions
2,435Shares Held
1.51BCall Options Held
29.7MPut Options Held
32.1M-
Vanguard Group Inc Valley Forge, PA187MShares$9.79 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.33 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.8 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$3.92 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.1 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $112B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...